Published online Apr 28, 2021. doi: 10.37126/aige.v2.i2.25
Peer-review started: March 5, 2021
First decision: March 14, 2021
Revised: March 17, 2021
Accepted: April 20, 2021
Article in press: April 20, 2021
Published online: April 28, 2021
Processing time: 53 Days and 22.2 Hours
Artificial intelligence (AI) has been widely involved in every aspect of healthcare in the preclinical stage. In the digestive system, AI has been trained to assist auxiliary examinations including histopathology, endoscopy, ultrasonography, computerized tomography, and magnetic resonance imaging in detection, diagnosis, classification, differentiation, prognosis, and quality control. In the field of endoscopy, the application of AI, such as automatic detection, diagnosis, classification, and invasion depth, in early gastrointestinal (GI) cancers has received wide attention. There is a paucity of studies of AI application on common GI benign diseases based on endoscopy. In the review, we provide an overview of AI applications to endoscopy on common GI benign diseases including in the esophagus, stomach, intestine, and colon. It indicates that AI will gradually become an indispensable part of normal endoscopic detection and diagnosis of common GI benign diseases as clinical data, algorithms, and other related work are constantly repeated and improved.
Core Tip: In endoscopy, the application of artificial intelligence in early gastrointestinal cancer has been widely concerned. We provide a general conclusion of artificial intelligence endoscopy applications in common gastrointestinal benign diseases, such as Barrett’s esophagus, atrophic gastritis, and colonic polyp. Studies indicate high accuracies and efficiencies. Further related work is needed to boost the real application of artificial intelligence in common gastrointestinal benign diseases in the future.